Abbott Laboratories |
Abstract
Untitled
|
Nigel Borshell, Taskin Ahmed |
|
AstraZeneca |
Abstract
|
Nigel Borshell, Taskin Ahmed |
|
Bayer Healthcare |
Abstract
|
Nigel Borshell, Taskin Ahmed |
|
Bristol-Myers Squibb |
Abstract
|
Nigel Borshell, Taskin Ahmed |
|
Eli Lilly |
Abstract
|
Nigel Borshell, Taskin Ahmed |
|
GlaxoSmithKline |
Abstract
|
Nigel Borshell, Taskin Ahmed |
|
Johnson & Johnson |
Abstract
|
Nigel Borshell, Taskin Ahmed |
|
Merck & Co |
Abstract
|
Nigel Borshell, Taskin Ahmed |
|
Novartis |
Abstract
|
Nigel Borshell, Taskin Ahmed |
|
Pfizer |
Abstract
|
Nigel Borshell, Taskin Ahmed |
|
Roche |
Abstract
|
Nigel Borshell, Taskin Ahmed |
|
Sanofi |
Abstract
|
Nigel Borshell, Taskin Ahmed |
|
GSK Moves up the M&A Rankings |
Abstract
|
Nigel Borshell, Taskin Ahmed |
|